|
Index of reports
> Cases resulting in life threatening events (8)
> Cases with General Physical Health Deterioration (2)
Below is the selection of adverse event reports related to Synagis (Palivizumab) that includes cases resulting in life threatening events where reactions include general physical health deterioration.
Adverse event in 2 month old male receiving Synagis (Palivizumab)
Reported by a physician from Japan on 2007-10-22
Patient: 2 month old male
Adverse reactions / side effects: Respiratory Failure, Condition Aggravated, General Physical Health Deterioration
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Synagis
Dosage: see image
Indication: Antiviral Prophylaxis
Start date: 2006-11-17
End date: 2006-12-21
Synagis
Dosage: see image
Indication: Antiviral Prophylaxis
Start date: 2006-11-17
Synagis
Dosage: see image
Indication: Antiviral Prophylaxis
Start date: 2007-01-24
Synagis
Dosage: see image
Indication: Antiviral Prophylaxis
Start date: 2007-02-22
Synagis
Dosage: see image
Indication: Antiviral Prophylaxis
Start date: 2007-03-23
Other drugs received by patient: Ferric Pyrophosphate (Ferric Pyrophosphate); Furosemide; Spironolactone; Levothyroxine Sodium Hydrate (Levothyroxine Sodium); Midazolam HCL; L-Carbocisteine (Carbocisteine); Pranlukast Hydrate (Pranlukast); Clarithromycin
Adverse event in 2 month old male receiving Synagis (Palivizumab)
Reported by a physician from Japan on 2007-10-09
Patient: 2 month old male
Adverse reactions / side effects: Respiratory Failure, Tachypnoea, General Physical Health Deterioration, Condition Aggravated
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Synagis
Dosage: 59 mg, 1 in 1 d, intramuscular; 48 mg, 1 in 1 d, intramuscular; intramuscular; intramuscular; intram
Indication: Antiviral Prophylaxis
Start date: 2006-11-17
End date: 2006-12-21
Synagis
Dosage: 59 mg, 1 in 1 d, intramuscular; 48 mg, 1 in 1 d, intramuscular; intramuscular; intramuscular; intram
Indication: Antiviral Prophylaxis
Start date: 2006-11-17
Synagis
Dosage: 59 mg, 1 in 1 d, intramuscular; 48 mg, 1 in 1 d, intramuscular; intramuscular; intramuscular; intram
Indication: Antiviral Prophylaxis
Start date: 2007-01-24
Synagis
Dosage: 59 mg, 1 in 1 d, intramuscular; 48 mg, 1 in 1 d, intramuscular; intramuscular; intramuscular; intram
Indication: Antiviral Prophylaxis
Start date: 2007-02-22
Synagis
Dosage: 59 mg, 1 in 1 d, intramuscular; 48 mg, 1 in 1 d, intramuscular; intramuscular; intramuscular; intram
Indication: Antiviral Prophylaxis
Start date: 2007-03-23
Other drugs received by patient: Ferric Pyrophosphate (Ferric Pyrophosphate); Furosemide; Spironolactone; Levothyroxine Sodium Hydrate (Levothyroxine Sodium); Midazolam HCL; L-Carbocisteine (Carbocisteine); Pranlukast Hydrate (Pranlukast); Clarithromycin
|
